After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Resmed Inc is listed on the NYSE in the Healthcare sector while operating in the Medical Instruments & Supplies industry. The current market capitalization of Resmed Inc is $34.46B. A total of 0.57 million shares were traded on the day, compared to an average of 878.00K shares.
In the most recent transaction, Sandercock Brett sold 1,000 shares of RMD for 238.98 per share on Feb 10 ’25. After the transaction, the Chief Financial Officer now owns 91,864 company shares. In a previous transaction on Feb 07 ’25, Farrell Michael J. sold 8,009 shares at 236.77 per share. RMD shares that Chief Executive Officer owns now total 455,472.
Among the insiders who bought shares, Sandercock Brett acquired of 1,000 shares on Feb 10 ’25 at a per-share price of $238.98. In another insider transaction, Farrell Michael J. bought 8,009 shares at $236.77 per share on Feb 07 ’25.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Resmed Inc pays an annual dividend of $2.07, resulting in a dividend yield of 0.88%, and it has a price to earnings (P/E) ratio of 27.72. RMD’s most recent ex-dividend date was 0.9% when it declared a $0.53 quarterly dividend that was paid in cash on 2/13/2025. Previously, the company paid the dividend on 11/7/2024 with an ex-dividend date of 0.8%. The RMD stock dividend was $0.53 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RMD has a high of $263.05 and a low of $170.56.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RMD’s latest balance sheet shows that the firm has $273.71M in Cash & Short Term Investments as of fiscal 2022. There were $917.55M in debt and $689.30M in liabilities at the time. Its Book Value Per Share was $35.77, while its Total Shareholder’s Equity was $3.36B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RMD is Buy with a score of 3.88.
